ENDRA Life Sciences (NDRA) Short Interest Ratio & Short Volume $7.20 +1.19 (+19.80%) Closing price 04:00 PM EasternExtended Trading$6.92 -0.29 (-3.96%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ENDRA Life Sciences Short Interest DataENDRA Life Sciences (NDRA) has a short interest of 44,700 shares, representing 7.95% of the float (the number of shares available for trading by the public). This marks a 41.46% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 133,489 shares to cover all short positions.Current Short Interest44,700 sharesPrevious Short Interest31,600 sharesChange Vs. Previous Month+41.46%Dollar Volume Sold Short$141,252.00Short Interest Ratio0.4 Days to CoverLast Record DateApril 15, 2025Outstanding Shares562,000 sharesFloat Size562,100 sharesShort Percent of Float7.95%Today's Trading Volume138,027 sharesAverage Trading Volume133,489 sharesToday's Volume Vs. Average103% Short Selling ENDRA Life Sciences? Sign up to receive the latest short interest report for ENDRA Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNDRA Short Interest Over TimeNDRA Days to Cover Over TimeNDRA Percentage of Float Shorted Over Time ENDRA Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202544,700 shares $141,252.00 +41.5%8.0%0.4 $3.16 3/31/202531,600 shares $127,980.00 -22.2%5.6%1 $4.05 3/15/202540,600 shares $166,460.00 +43.5%7.6%2.1 $4.10 2/28/202528,300 shares $122,539.00 -9.3%5.3%1.1 $4.33 2/15/202531,200 shares $156,468.00 -6.0%5.8%0.7 $5.02 1/31/202533,200 shares $167,792.80 -15.7%6.2%0.4 $5.05 1/15/202539,400 shares $236,400.00 -24.5%7.3%0.2 $6.00 12/31/202452,200 shares $326,772.00 +15.2%9.7%0.2 $6.26 12/15/202445,300 shares $193,431.00 -32.3%8.4%0.2 $4.27 11/30/202466,900 shares $381,999.00 +6.9%12.5%0.3 $5.71 Get the Latest News and Ratings for NDRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 11/15/202462,600 shares $284,204.00 +160.8%11.7%0.2 $4.54 10/31/202424,000 shares $211,260.00 -96.7%4.6%0.1 $8.80 10/15/2024717,700 shares $149,999.30 +167.7%4.0%0.1 $0.21 9/30/2024268,100 shares $53,888.10 +324.2%1.5%0.1 $0.20 9/15/202463,200 shares $14,536.00 -65.7%0.4%0 $0.23 8/31/2024184,200 shares $70,493.34 +11.7%1.0%0.1 $0.38 8/15/2024164,900 shares $21.44 million -24.5%11.4%0.1 $130.00 7/31/2024218,500 shares $17,152.25 -5.9%N/A0 $0.08 7/15/2024232,100 shares $21,260.36 -29.3%N/A0 $0.09 6/30/2024328,200 shares $31,868.22 -75.0%N/A0 $0.10 6/15/20241,310,000 shares $135,716.00 +371.9%N/A0.1 $0.10 5/31/2024277,600 shares $74,674.40 +165.1%2.6%0 $0.27 5/15/2024104,700 shares $30,415.35 +2,517.5%1.0%0.6 $0.29 4/30/20244,000 shares $1,131.60 -47.4%0.0%0 $0.28 4/15/20247,600 shares $1,991.20 -75.2%0.1%0 $0.26 3/31/202430,600 shares $17,748.00 -36.9%0.3%0.2 $0.58 3/15/202448,500 shares $48,500.00 -11.3%0.5%0.3 $1.00 2/29/202454,700 shares $61,264.00 +86.1%0.5%0.4 $1.12 2/15/202429,400 shares $33,810.00 +47.7%0.4%0.3 $1.15 1/31/202419,900 shares $20,895.00 -73.7%0.2%0.2 $1.05 1/15/202475,700 shares $98,410.00 -41.8%0.9%0.8 $1.30 12/31/2023130,000 shares $275,600.00 -25.5%1.6%1.4 $2.12 12/15/2023174,500 shares $251,280.00 -17.3%2.1%2.3 $1.44 11/30/2023211,100 shares $206,434.69 -11.8%2.6%1.9 $0.98 11/15/2023239,300 shares $227,335.00 -6.1%2.9%2.4 $0.95 10/31/2023254,900 shares $251,076.50 +56.5%3.5%2.2 $0.99 10/15/2023162,900 shares $169,416.00 +28.9%2.2%1.4 $1.04 9/30/2023126,400 shares $140,316.64 +175.4%1.7%1.1 $1.11 9/15/202345,900 shares $56,457.00 -37.1%0.6%0.4 $1.23 8/31/202373,000 shares $85,410.00 +5.5%1.0%1.2 $1.17Musk's warning signal: Prepare before the cascade begins (Ad)When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.Watch the Musk market warning before the dominoes fall 8/15/202369,200 shares $79,580.00 +61.7%0.9%1.1 $1.15 7/31/202342,800 shares $53,072.00 -20.0%0.6%0.8 $1.24 7/15/202353,500 shares $72,760.00 -36.5%0.7%0.8 $1.36 6/30/202384,300 shares $118,020.00 +13.2%1.2%1.3 $1.40 6/15/202374,500 shares $109,515.00 +40.0%1.0%1.4 $1.47 5/31/202353,200 shares $78,204.00 +54.7%0.8%1.2 $1.47 5/15/202334,400 shares $44,032.00 -70.1%0.5%1 $1.28 4/30/2023114,900 shares $183,840.00 +61.2%1.9%3.9 $1.60 4/15/202371,300 shares $131,905.00 +124.2%2.4%5.7 $1.85 3/31/202331,800 shares $72,818.82 -7.8%1.1%2.6 $2.29 3/15/202334,500 shares $124,200.00 +24.1%1.2%2.6 $3.60 2/28/202327,800 shares $108,420.00 -7.6%0.9%1.3 $3.90 2/15/202330,100 shares $111,370.00 -9.1%1.0%1.4 $3.70 1/31/202333,100 shares $132,731.00 -23.2%1.1%1.4 $4.01 1/15/202343,100 shares $202,570.00 +28.3%1.4%1.8 $4.70 12/30/202233,600 shares $136,752.00 -54.4%1.1%1.4 $4.07 12/15/202273,600 shares $374,624.00 +173.6%2.4%3.2 $5.09 11/30/202226,900 shares $4,777.44 -95.5%0.9%2 $0.18 11/15/2022597,800 shares $119,679.56 +8.8%N/A2.2 $0.20 10/31/2022549,600 shares $126,408.00 -19.7%N/A1.9 $0.23 10/15/2022684,800 shares $208,521.60 -11.7%N/A2.1 $0.30 9/30/2022775,300 shares $237,241.80 +0.1%N/A2.1 $0.31 9/15/2022774,500 shares $278,820.00 +11.5%N/A1.9 $0.36 8/31/2022694,700 shares $202,643.99 -8.8%N/A1.5 $0.29 8/15/2022761,900 shares $275,045.90 +17.1%N/A1.3 $0.36 7/31/2022650,600 shares $178,784.88 -6.2%N/A0.8 $0.27 7/15/2022693,400 shares $163,919.76 -17.9%N/A0.6 $0.24 6/30/2022844,400 shares $196,745.20 +97.2%N/A0.3 $0.23 6/15/2022428,200 shares $102,768.00 -55.0%N/A0.1 $0.24 5/31/2022952,400 shares $219,052.00 +282.3%N/A0.3 $0.23 5/15/2022249,100 shares $49,570.90 -86.9%N/A0.1 $0.20 4/30/20221,900,000 shares $492,860.00 -12.0%N/A0.8 $0.26 4/15/20222,160,000 shares $559,440.00 +285.8%N/A0.9 $0.26 3/31/2022559,900 shares $218,361.00 +30.2%N/A0.4 $0.39 3/15/2022430,200 shares $167,778.00 +32.1%1.1%1.6 $0.39 2/28/2022325,600 shares $139,356.80 -11.2%0.8%1.2 $0.43 2/15/2022366,500 shares $160,893.50 +16.8%0.9%1.2 $0.44 1/31/2022313,900 shares $188,340.00 -38.4%0.8%1 $0.60 1/15/2022509,300 shares $352,944.90 -1.4%1.2%1.6 $0.69 12/31/2021516,400 shares $357,245.52 +5.2%1.3%1.7 $0.69 12/15/2021491,000 shares $374,142.00 -11.9%1.2%1.8 $0.76 11/30/2021557,200 shares $530,510.12 -45.4%1.4%2.2 $0.95 11/15/20211,020,000 shares $1.36 million -15.0%2.5%4 $1.33 10/29/20211,200,000 shares $1.90 million +9.1%2.9%4.4 $1.58 10/15/20211,100,000 shares $1.74 million -10.6%2.7%4.2 $1.58 9/30/20211,230,000 shares $2.13 million +0.8%3.0%4.2 $1.73 9/15/20211,220,000 shares $2.12 million +1.7%3.0%3.5 $1.74 8/31/20211,200,000 shares $2.28 million +53.4%2.9%3.1 $1.90 8/13/2021782,100 shares $1.27 million -27.6%1.9%1.9 $1.62 7/30/20211,080,000 shares $1.94 million +30.6%2.7%2.5 $1.80Musk's warning signal: Prepare before the cascade begins (Ad)When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.Watch the Musk market warning before the dominoes fall 7/15/2021827,100 shares $1.55 million +7.9%2.0%1.5 $1.87 6/30/2021766,800 shares $1.67 million -4.1%1.9%1.2 $2.18 6/15/2021799,200 shares $1.71 million +28.2%2.0%1 $2.14 5/28/2021623,400 shares $1.32 million -46.3%1.5%0.6 $2.12 5/14/20211,160,000 shares $2.30 million -10.8%N/A0.8 $1.98 4/30/20211,300,000 shares $3.21 million -3.7%N/A0.7 $2.47 4/15/20211,350,000 shares $3.08 million +13.5%N/A0.6 $2.28 3/31/20211,190,000 shares $3.06 million +304.4%N/A0.4 $2.57 3/15/2021294,300 shares $735,750.00 -34.1%N/A0.1 $2.50 2/26/2021446,800 shares $1.10 million +19.6%N/A0.2 $2.46 2/12/2021373,700 shares $852,036.00 -61.8%N/A0.1 $2.28 1/29/2021979,400 shares $1.97 million +98.2%N/A0.4 $2.01 1/15/2021494,200 shares $499,142.00 +3.6%N/A0.3 $1.01 12/31/2020476,900 shares $355,290.50 -11.2%N/A0.9 $0.75 12/15/2020537,300 shares $482,925.24 -2.2%N/A1.7 $0.90 11/30/2020549,600 shares $467,434.80 +5.1%N/A3.2 $0.85 11/15/2020522,900 shares $441,327.60 -12.7%N/A3.7 $0.84 10/30/2020598,900 shares $430,070.09 +3.5%N/A4 $0.72 10/15/2020578,800 shares $421,655.80 +0.2%N/A2.6 $0.73 9/30/2020577,800 shares $422,660.70 -1.9%N/A1.9 $0.73 9/15/2020588,800 shares $471,040.00 -1.2%N/A1.4 $0.80 8/31/2020595,700 shares $488,474.00 -2.6%N/A1.2 $0.82 8/14/2020611,300 shares $562,396.00 +7.8%N/A1.2 $0.92 7/31/2020567,200 shares $558,692.00 -1.2%N/A1.1 $0.99 7/15/2020573,900 shares $511,230.12 +2.6%N/A1.1 $0.89 6/30/2020559,600 shares $570,792.00 -9.8%N/A1.4 $1.02 6/15/2020620,400 shares $536,708.04 +0.1%N/A2.1 $0.87 5/29/2020619,700 shares $570,124.00 -0.2%N/A2.7 $0.92 5/15/2020620,800 shares $444,058.24 -3.6%N/A3.4 $0.72 NDRA Short Interest - Frequently Asked Questions What is ENDRA Life Sciences' current short interest? Short interest is the volume of ENDRA Life Sciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 44,700 shares of NDRA short. 7.95% of ENDRA Life Sciences' shares are currently sold short. Learn More on ENDRA Life Sciences' current short interest. What is a good short interest percentage for ENDRA Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.95% of ENDRA Life Sciences' floating shares are currently sold short. Is ENDRA Life Sciences' short interest increasing or decreasing? ENDRA Life Sciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 44,700 shares, an increase of 41.5% from the previous total of 31,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ENDRA Life Sciences' float size? ENDRA Life Sciences currently has issued a total of 562,000 shares. Some of ENDRA Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ENDRA Life Sciences currently has a public float of 562,100 shares. How does ENDRA Life Sciences' short interest compare to its competitors? 7.95% of ENDRA Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to ENDRA Life Sciences: Meihua International Medical Technologies Co., Ltd. (0.43%), Inspira Technologies Oxy B.H.N. Ltd. (0.38%), Tenon Medical, Inc. (2.27%), DIH Holding US, Inc. (0.50%), Star Equity Holdings, Inc. (0.83%), Lyra Therapeutics, Inc. (3.56%), Aethlon Medical, Inc. (0.39%), NanoVibronix, Inc. (13.35%), Sintx Technologies, Inc. (7.03%), Autonomix Medical, Inc. (4.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short ENDRA Life Sciences stock? Short selling NDRA is an investing strategy that aims to generate trading profit from ENDRA Life Sciences as its price is falling. NDRA shares are trading up $1.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ENDRA Life Sciences? A short squeeze for ENDRA Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NDRA, which in turn drives the price of the stock up even further. How often is ENDRA Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NDRA, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies MHUA Short Interest IINN Short Interest TNON Short Interest DHAI Short Interest STRR Short Interest LYRA Short Interest AEMD Short Interest NAOV Short Interest SINT Short Interest AMIX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NDRA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NDRA Stock Free NDRA Stock Alerts